Reps. Eliot Engel, D-N.Y., and Larry Bucshon, R-Ind., have introduced the Advancing Education on Biosimilars Act of 2019, which would create federal programs to promote the use of use cost-effective biosimilar drugs. Among other areas, the AHA-supported bill would require the Food and Drug Administration to create a public website to educate patients and providers about biological and biosimilar products. The website will include materials about which biologicals and biosimilars may be interchangeable, and processes for reporting adverse events that pose a risk to patient health and safety. The bill also will require development of continuing education programs for health care providers. “America’s hospitals and health systems thank Reps. Engel and Bucshon for their bipartisan efforts to facilitate the increased use of biosimilar drugs, including the importance of interchangeability, by educating providers, patients and other key stakeholders on their clinical value,” said AHA Executive Vice President Tom Nickels. “This will give patients greater access to affordable, innovative drugs.” Sens. Mike Enzi, R-Wyo., and Maggie Hassan, D-N.H., earlier this year introduced companion legislation that was included in S. 1895, the Lower Health Care Costs Act, that passed the Senate Committee on Health, Education, Labor and Pensions in June.

Related News Articles

Headline
The Senate narrowly passed the One Big Beautiful Bill Act (H.R. 1) on July 1 by a 50-50 tally, with Vice President J.D. Vance casting the tie-breaking vote.…
Headline
The AHA June 29 sent a letter to senators urging them to amend the budget reconciliation bill before its final passage in the Senate. The Senate version of the…
Headline
The AHA June 16 released a fact sheet with analysis on the impact to rural patients and hospitals from proposed Medicaid cuts by Congress. The analysis found…
Headline
Data from the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill shows that health care cuts under…
Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…
Headline
Sens. Chuck Schumer, D-N.Y., Susan Collins, R-Maine, and Andy Kim, D-N.J., June 5 reintroduced the SEPSIS Act, legislation which would task the Centers for…